Major Pharmaceutical Company Partners with Canadian MMJ Firm for Non-Smokable Products
By TG Branfalt
The fourth largest pharmaceutical company in the world by revenue, Novartis International AG, is partnering with Canadian medical cannabis company Tilray to develop and distribute medical cannabis products. The partnership will be spearheaded by Sandoz Canada, an arm of Sandoz International GmbH, which is the generics-focused branch of Novartis.
The companies will co-develop and market non-smokable medical cannabis products and, if regulations allow, Sandoz will wholesale and distribute the products to Canadian hospitals and pharmacies.